For the quarter ending 2025-09-30, EXFY had $1,953K increase in cash & cash equivalents over the period. $4,166K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -2,315 | -11,957 |
| Depreciation and amortization | 2,138 | 4,041 |
| Reduction of operating lease right-of-use assets | 148 | 279 |
| Loss on impairment, receivables and sale or disposal of equipment | -114 | -334 |
| Stock-based compensation expense | 6,663 | 14,917 |
| Amortization of original issue discount and debt issuance costs | 22 | 57 |
| Deferred tax assets | 6 | -4 |
| Accounts receivable, net | 162 | -212 |
| Settlement assets, net | -3,708 | 11,614 |
| Prepaid expenses | 1,650 | -9,565 |
| Other current assets | 378 | 2,186 |
| Other assets | -25 | 19 |
| Accounts payable | -885 | 1,336 |
| Accrued expenses and other liabilities | -1,312 | 962 |
| Operating lease liabilities | -154 | -281 |
| Settlement liabilities | -1,855 | 8,248 |
| Other liabilities | 53 | -169 |
| Net cash provided by operating activities | 4,166 | 13,721 |
| Purchases of property and equipment | 0 | 17 |
| Software development costs | 1,085 | 1,655 |
| Net cash used in investing activities | -1,085 | -1,672 |
| Principal payments of finance leases | 36 | 68 |
| Principal payments of outstanding debt | 0 | 0 |
| Payments for debt issuance costs | 0 | 88 |
| Repurchases of early exercised stock options | 0 | 0 |
| Proceeds from common stock purchased under matching plan | 1,741 | 2,610 |
| Proceeds from issuance of common stock upon exercise of stock options | 198 | 117 |
| Repurchase and retirement of common stock | 3,031 | 3,026 |
| Net cash used in financing activities | -1,128 | -455 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 1,953 | 11,594 |
| Cash and cash equivalents at beginning of period | 90,834 | - |
| Cash and cash equivalents at end of period | 104,381 | - |
Expensify, Inc. (EXFY)
Expensify, Inc. (EXFY)